SOX4 Mediates TGF-β-Induced Expression of Mesenchymal Markers during Mammary Cell Epithelial to Mesenchymal Transition

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Vervoort, Stephin J ^a,b   Lourenço, Ana Rita ^a   van Boxtel, Ruben ^a   Coffer, Paul J ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; NERVE CELL ADHESION MOLECULE; TRANSCRIPTION FACTOR SOX4; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; VIMENTIN; VIRUS SMALL T ANTIGEN;

AMINO ACID SEQUENCE; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CONTROLLED STUDY; EMBRYO; EPITHELIAL MESENCHYMAL TRANSITION; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; UPREGULATION;

BASE SEQUENCE; CADHERINS; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; DOWN-REGULATION; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FIBRONECTINS; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; MAMMARY GLANDS, HUMAN; MICROSCOPY, CONFOCAL; MOLECULAR SEQUENCE DATA; PHENOTYPE; RNA, MESSENGER; RNA, SMALL INTERFERING; SOXC TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; VIMENTIN;

EID: 84871858845     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053238     Document Type: Article

References (43)

1. Thiery JP, Acloque H, Huang RY, Nieto MA, (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
2. Kalluri R, Weinberg RA, (2009) The basics of epithelial-mesenchymal transition. The Journal of clinical investigation 119: 1420-1428.
3. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.
4. Polyak K, Weinberg RA, (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nature reviews Cancer 9: 265-273.
5. Zhang YE, (2009) Non-Smad pathways in TGF-beta signaling. Cell research 19: 128-139.
6. Hulit J, Suyama K, Chung S, Keren R, Agiostratidou G, et al. (2007) N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation. Cancer research 67: 3106-3116.
7. Mani SA, Yang J, Brooks M, Schwaninger G, Zhou A, et al. (2007) Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proceedings of the National Academy of Sciences of the United States of America 104: 10069-10074.
8. van der Vos KE, Eliasson P, Proikas-Cezanne T, Vervoort SJ, van Boxtel R, et al. (2012) Modulation of glutamine metabolism by the PI(3)K-PKB-FOXO network regulates autophagy. Nature cell biology 14: 829-837.
9. Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, et al. (2010) Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proceedings of the National Academy of Sciences of the United States of America 107: 15449-15454.
10. Xu D, Dwyer J, Li H, Duan W, Liu JP, (2008) Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc. The Journal of biological chemistry 283: 23567-23580.
11. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, et al. (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451: 147-152.
12. Magnani L, Ballantyne EB, Zhang X, Lupien M, (2011) PBX1 genomic pioneer function drives ERalpha signaling underlying progression in breast cancer. PLoS genetics 7: e1002368.
13. Suzuki H, Forrest AR, van Nimwegen E, Daub CO, Balwierz PJ, et al. (2009) The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line. Nature genetics 41: 553-562.
14. Liu Z, Wang M, Alvarez JV, Bonney ME, Chen CC, et al. (2008) Singular value decomposition-based regression identifies activation of endogenous signaling pathways in vivo. Genome biology 9: R180.
15. Hesling C, Fattet L, Teyre G, Jury D, Gonzalo P, et al. (2011) Antagonistic regulation of EMT by TIF1gamma and Smad4 in mammary epithelial cells. EMBO reports 12: 665-672.
16. Littlewood TD, Hancock DC, Danielian PS, Parker MG, Evan GI, (1995) A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic acids research 23: 1686-1690.
17. Geijsen N, Uings IJ, Pals C, Armstrong J, McKinnon M, et al. (2001) Cytokine-specific transcriptional regulation through an IL-5Ralpha interacting protein. Science 293: 1136-1138.
18. Panda DK, Miao D, Lefebvre V, Hendy GN, Goltzman D, (2001) The transcription factor SOX9 regulates cell cycle and differentiation genes in chondrocytic CFK2 cells. The Journal of biological chemistry 276: 41229-41236.
19. Beekman JM, Vervoort SJ, Dekkers F, van Vessem ME, Vendelbosch S, et al. (2012) Syntenin-mediated regulation of Sox4 proteasomal degradation modulates transcriptional output. Oncogene 31: 2668-2679.
20. Broos S, Hulpiau P, Galle J, Hooghe B, Van Roy F, et al. (2011) ConTra v2: a tool to identify transcription factor binding sites across species, update 2011. Nucleic acids research 39: W74-78.
21. Wendt MK, Taylor MA, Schiemann BJ, Schiemann WP, (2011) Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer. Molecular biology of the cell 22: 2423-2435.
22. Thiery JP, (2002) Epithelial-mesenchymal transitions in tumour progression. Nature reviews Cancer 2: 442-454.
23. Dy P, Penzo-Mendez A, Wang H, Pedraza CE, Macklin WB, et al. (2008) The three SoxC proteins-Sox4, Sox11 and Sox12-exhibit overlapping expression patterns and molecular properties. Nucleic acids research 36: 3101-3117.
24. Schilham MW, Oosterwegel MA, Moerer P, Ya J, de Boer PA, et al. (1996) Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4. Nature 380: 711-714.
25. Vervoort SJ, van Boxtel R, Coffer PJ (2012) The role of SRY-related HMG box transcription factor 4 (SOX4) in tumorigenesis and metastasis: friend or foe? Oncogene in press.
26. Bhattaram P, Penzo-Mendez A, Sock E, Colmenares C, Kaneko KJ, et al. (2010) Organogenesis relies on SoxC transcription factors for the survival of neural and mesenchymal progenitors. Nature communications 1: 9.
27. Sock E, Rettig SD, Enderich J, Bosl MR, Tamm ER, et al. (2004) Gene targeting reveals a widespread role for the high-mobility-group transcription factor Sox11 in tissue remodeling. Molecular and cellular biology 24: 6635-6644.
28. Derynck R, Akhurst RJ, (2007) Differentiation plasticity regulated by TGF-beta family proteins in development and disease. Nature cell biology 9: 1000-1004.
29. Zimmermann P, Tomatis D, Rosas M, Grootjans J, Leenaerts I, et al. (2001) Characterization of syntenin, a syndecan-binding PDZ protein, as a component of cell adhesion sites and microfilaments. Molecular biology of the cell 12: 339-350.
30. Beekman JM, Coffer PJ, (2008) The ins and outs of syntenin, a multifunctional intracellular adaptor protein. Journal of cell science 121: 1349-1355.
31. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, et al. (2004) Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proceedings of the National Academy of Sciences of the United States of America 101: 9309-9314.
32. Castillo SD, Matheu A, Mariani N, Carretero J, Lopez-Rios F, et al. (2012) Novel transcriptional targets of the SRY-HMG box transcription factor SOX4 link its expression to the development of small cell lung cancer. Cancer research 72: 176-186.
33. Liu P, Ramachandran S, Ali Seyed M, Scharer CD, Laycock N, et al. (2006) Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells. Cancer research 66: 4011-4019.
34. Pramoonjago P, Baras AS, Moskaluk CA, (2006) Knockdown of Sox4 expression by RNAi induces apoptosis in ACC3 cells. Oncogene 25: 5626-5639.
35. Liao YL, Sun YM, Chau GY, Chau YP, Lai TC, et al. (2008) Identification of SOX4 target genes using phylogenetic footprinting-based prediction from expression microarrays suggests that overexpression of SOX4 potentiates metastasis in hepatocellular carcinoma. Oncogene 27: 5578-5589.
36. Giannelli G, Mazzocca A, Fransvea E, Lahn M, Antonaci S, (2011) Inhibiting TGF-beta signaling in hepatocellular carcinoma. Biochimica et biophysica acta 1815: 214-223.
37. Ikushima H, Todo T, Ino Y, Takahashi M, Miyazawa K, et al. (2009) Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell stem cell 5: 504-514.
38. Kuwahara M, Yamashita M, Shinoda K, Tofukuji S, Onodera A, et al. (2012) The transcription factor Sox4 is a downstream target of signaling by the cytokine TGF-beta and suppresses T(H)2 differentiation. Nature immunology.
39. Pece S, Tosoni D, Confalonieri S, Mazzarol G, Vecchi M, et al. (2010) Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 140: 62-73.
40. Zhang J, Liang Q, Lei Y, Yao M, Li L, et al. (2012) SOX4 Induces Epithelial-Mesenchymal Transition and Contributes to Breast Cancer Progression. Cancer research 72: 4597-4608.
41. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ, (1999) N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. The Journal of cell biology 147: 631-644.
42. Su Y, Li J, Witkiewicz AK, Brennan D, Neill T, et al. (2012) N-cadherin haploinsufficiency increases survival in a mouse model of pancreatic cancer. Oncogene 31: 4484-4489.
43. Tanaka H, Kono E, Tran CP, Miyazaki H, Yamashiro J, et al. (2010) Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance. Nature medicine 16: 1414-1420.